Nutex Health Statistics
Total Valuation
Nutex Health has a market cap or net worth of $30.12 million. The enterprise value is $283.87 million.
| Market Cap | 30.12M |
| Enterprise Value | 283.87M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nutex Health has 49.70 million shares outstanding. The number of shares has increased by 3.23% in one year.
| Shares Outstanding | 49.70M |
| Shares Change (YoY) | +3.23% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 43.41% |
| Owned by Institutions (%) | 5.51% |
| Float | 27.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.12 |
| Forward PS | 0.10 |
| PB Ratio | 0.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 4.49.
| Current Ratio | 1.56 |
| Quick Ratio | 1.45 |
| Debt / Equity | 4.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.12 |
Financial Efficiency
Return on equity (ROE) is -54.40% and return on invested capital (ROIC) is -9.42%.
| Return on Equity (ROE) | -54.40% |
| Return on Assets (ROA) | -10.50% |
| Return on Capital (ROIC) | -9.42% |
| Revenue Per Employee | $309,558 |
| Profits Per Employee | -$57,233 |
| Employee Count | 800 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 61.49 |
Taxes
| Income Tax | -5.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.44% in the last 52 weeks. The beta is 1.14, so Nutex Health's price volatility has been higher than the market average.
| Beta (1Y) | 1.14 |
| 52-Week Price Change | -92.44% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.91 |
| Relative Strength Index (RSI) | 24.42 |
| Average Volume (30 Days) | 276,348 |
Short Selling Information
The latest short interest is 178,799, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 178,799 |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.64% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
In the last 12 months, Nutex Health had revenue of $247.65 million and -$45.79 million in losses. Loss per share was -$1.05.
| Revenue | 247.65M |
| Gross Profit | 34.77M |
| Operating Income | -31.77M |
| Pretax Income | -50.85M |
| Net Income | -45.79M |
| EBITDA | -16.81M |
| EBIT | -34.54M |
| Loss Per Share | -$1.05 |
Balance Sheet
The company has $22.00 million in cash and $275.76 million in debt, giving a net cash position of -$253.75 million or -$5.11 per share.
| Cash & Cash Equivalents | 22.00M |
| Total Debt | 275.76M |
| Net Cash | -253.75M |
| Net Cash Per Share | -$5.11 |
| Equity / Book Value | 61.45M |
| Book Value Per Share | 1.24 |
| Working Capital | 32.54M |
Cash Flow
In the last 12 months, operating cash flow was $1.26 million and capital expenditures -$9.50 million, giving a free cash flow of -$8.24 million.
| Operating Cash Flow | 1.26M |
| Capital Expenditures | -9.50M |
| Free Cash Flow | -8.24M |
| FCF Per Share | -$0.18 |
Margins
Gross margin is 14.04%, with operating and profit margins of -12.83% and -18.49%.
| Gross Margin | 14.04% |
| Operating Margin | -12.83% |
| Pretax Margin | -20.53% |
| Profit Margin | -18.49% |
| EBITDA Margin | -6.79% |
| EBIT Margin | -13.95% |
| FCF Margin | -3.33% |
Dividends & Yields
Nutex Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.23% |
| Shareholder Yield | -3.23% |
| Earnings Yield | -152.04% |
| FCF Yield | -27.36% |
Analyst Forecast
The average price target for Nutex Health is $15.00, which is 2,375.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 2,375.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 10, 2024. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 10, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Nutex Health has an Altman Z-Score of -0.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.95 |
| Piotroski F-Score | 4 |